Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Prostate Cancer|Urinary Bladder Cancer
Interventions: DRUG: Injection of 68Ga-NOTA-AE105|DEVICE: Positron Emission Tomography scans
Sponsor: Rigshospitalet, Denmark
Collaborators: Curasight